A Study of Delayed and Extended Release Formulation of Dextroamphetamine Sulfate (HLD100) in Children With ADHD
Clinical trial NCT02884544 · COMPLETED
Trial details
- NCT number
- NCT02884544
- Sponsor
- Ironshore Pharmaceuticals and Development, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2016-12-18
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.